verified SJR 0,881 · Q2 • database Scopus / SJR & Web of Science indexed

United States · SAGE Publications Ltd

workspace_premium Q2 — Medicine (miscellaneous) lock_open Open Access

Cancer Control

Cancer Control is a journal indexed in SJR in Medicine (miscellaneous) and Hematology with an H index of 83. It has an SJR impact factor of 0,881 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,881.

ISSN: 1073-2748

Publisher: SAGE Publications Ltd

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,881 Q2

H-index 83

Acceptance rate pie_chart

27% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,881

H-index

Docs (year)

218

Docs 3y

454

Total refs

11757

Cites 3y

1271

Citable 3y

440

Cites/Doc 2y

2.66

Ref/Doc

53.93

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Chronic Lymphocytic Leukemia in the Elderly: Epidemiology and Proposed Patient-Related Approach

Yoga for Cancer Patients and Survivors

Economic Impact of the Growing Population of Breast Cancer Survivors

Does Androgen Deprivation Therapy for Prostate Cancer Increase the Risk of Colorectal Cancer?

Disparities in Adolescents and Young Adults with Cancer

Developments in Intralesional Therapy for Metastatic Melanoma

Department of Head and Neck and Endocrine Oncology

Contemporary Management of Superficial Bladder Cancer

Construction and Validation of a Multi-Institutional Tissue Microarray of Invasive Ductal Carcinoma from Racially and Ethnically Diverse Populations

Comparison of Outcomes Between McKeown and Sweet Esophagectomy in the Elderly Patients for Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis

Colorectal Cancer: The Last Nail in the Coffin for Androgen Deprivation Therapy for Prostate Cancer?

Clinical Considerations of Risk, Incidence, and Outcomes of Breast Cancer in Sexual Minorities

SHOW MORE ARTICLES

Circulating Tumor Cells: A Window into Tumor Development and Therapeutic Effectiveness

A Model Shows Utility in Predicting Postoperative Recurrence and Distant Metastasis in Curatively Resected Esophageal Squamous Cell Cancer

Chronic Lymphocytic Leukemia in the Elderly, Which Investigations Are Necessary: A Map for the Practicing Oncologist

Cerebrospinal Fluid (Vascular Endothelial Growth Factor) and Serologic (Recoverin) Tumor Markers for Malignant Glioma

Cancer Genetics Knowledge and Beliefs and Receipt of Results in Ashkenazi Jewish Individuals Receiving Counseling for BRCA1/2 Mutations

Building Community Capacity to Participate in Cancer Prevention Research

Bordetella pertussis Infection in Patients with Cancer

Bladder Cancer in Lebanon

Association of microRNA 21 with Biological Features and Prognosis of Neuroblastoma

Association Between Positive Cultures During Admission and 1-Year Mortality in Patients With Cancer Receiving Perioperative Intensive Care

Assessing Prognosis in Uveal Melanoma

Aging, Frailty, and Chemotherapy

FAQs

Cancer Control has an SJR of 0,881 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Cancer Control is 27%.

Cancer Control

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Cancer Control?

What is the APC / publication cost?

What is the acceptance rate?